The Cardiac Membrane Biology Laboratory aims to improve the lives of people suffering cardiac related health issues.
Our research focuses on one of the body’s most crucial molecules – a molecule which is vital for the contraction of heart cells and therefore the pumping of the heart. As we develop a better understanding of this molecule through laboratory-based experiments, we explore treatments for heart failure, irregular heartbeat and heart damage following cancer treatment.
Our laboratory-based research has led to the discovery of a new potential treatment for heart failure. We are about to begin a clinical trial of this approach with our collaborators based in Denmark.
Chair of Cardiology
Medicine, Northern Clinical School
Laboratory Manager
Medicine, Northern Clinical School
Honorary Senior Research Fellow
This project will investigate a new drug combination therapy that has potential benefits in cancer treatment induced heart failure by targeting the sodium/potassium pump function.
This project will investigate a drug combination therapy that has potential benefits in heart failure treatment by targeting the sodium/potassium pump function.
Some recent media:
Posted on: 27 February, 2023
Kolling Institute Governance Committee Chair Michael Nugent said it is encouraging to see more than ..... Read more
Category: Research Excellence
Posted on: 20 February, 2023
A collection of emerging research leaders will have the chance to broaden their research experience ..... Read more
Category: Awards, Research Excellence
Posted on: 14 February, 2023
We are pleased to announce the successful recipients of our annual Kolling Institute awards program...... Read more
Category: Awards, Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research